Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07146165

Clinical Evaluation of a New Platform for Bi-manual Endoscopic Resection in the Rectum and Sigma (EndoTEM)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to determine whether the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon is feasible and safe. The main questions it aims to answer are: * Is the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon feasible (i.e., does it enable complete resection of the polyp)? * Is the use of the EndoTEM system during the endoscopic removal of polyps in the distal colon safe? Participants will: * be treated with the EndoTEM system during the endoscopic submucosal dissection of polyps in the distal colon. * answere questionnaires on fecal continence and quality of life before and after the intervention. * be treated following standard clinical procedures before, during and after the endoscopic removal.

Conditions

Interventions

TypeNameDescription
DEVICEEndoTEM resection platform and techniqueEndoTEM is a flexible transanally introduced port system that allows the insertion of a second instrument alongside the flexible endoscope. A curved rigid grasping instrument has been developed, with a 2 cm long tip that can be rotated and angled in all directions.

Timeline

Start date
2025-10-02
Primary completion
2028-08-01
Completion
2028-08-01
First posted
2025-08-28
Last updated
2026-03-31

Locations

3 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT07146165. Inclusion in this directory is not an endorsement.